From: Analysis of the therapeutic effect and prognosis in 86 cases of rib fractures and atelectasis
Group | n | SpO2 (%) | Changes in the pulmonary function FEV1% | Secondary pulmonary infection (n) | Secondary thoracic cavity infection (n) | Chest tube drainage time (days) | Length of stay (days) | Expense of hospitalization (Yuan) | Quality of life satisfaction (%) | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Before reexpansion | After reexpansion | Before reexpansion | After reexpansion | ||||||||
Reexpansion group | 49 | 88.90 ± 1.1 | 98.2 ± 0.17* | 60.80 ± 1.36 | 82.13 ± 0.15* | 13* | 5* | 8.02 ± 1.5 | 20.98 ± 4.5 | 29286.52 ± 8321.89* | 96* |
Non-reexpansion group | 37 | 90.10 ± 1.06 | 61.00 ± 1.03 | 26 | 15 | 7.88 ± 3.3 | 19.67 ± 5.9 | 8686.56 ± 2102.6 | 56.25 |